TGM2 induces chemoresistance in cancer cells by modulating extracellular matrix structure, inducing EMT, activating survival pathways, especially Wnt/β-catenin signaling, and inhibiting apoptosis and autophagy [72,73]. The gene discussed is TGM2; the disease is cancer.